Oncogenic transformation by SEI-1 is associated with chromosomal instability

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• SEI-1, a cell cycle regulatory gene located at 19q13.1, is frequently amplified in ovarian cancer.
• Amplification suggests SEI-1 may play a role in ovarian cancer pathogenesis.

Purpose of the Study:

• To investigate the oncogenic potential of SEI-1 in ovarian cancer.
• To elucidate the mechanisms underlying SEI-1's role in tumorigenesis and progression.

Main Methods:

• SEI-1 oncogenic potential assessed via anchorage-independent growth and tumor formation in SEI-1-transfected NIH 3T3 cells.
• SEI-1 gene silencing in SKOV3 ovarian cancer cells using small interfering RNAs.
• Analysis of chromosomal alterations, including double minutes and micronuclei formation, in SEI-1-transformed cells.
• Correlation of SEI-1 overexpression with tumor grade and FIGO stage in ovarian carcinomas.

Main Results:

• SEI-1 transfection induced anchorage-independent growth and tumor formation in NIH 3T3 cells.
• Silencing SEI-1 inhibited SKOV3 cell growth and soft agar colony formation.
• SEI-1 transformation led to chromosomal abnormalities and increased micronuclei formation, indicating genomic instability.
• Overexpression of SEI-1 correlated with higher tumor grades and advanced FIGO stages in ovarian cancer patients.

Conclusions:

• SEI-1 exhibits oncogenic potential and contributes to ovarian cancer development.
• SEI-1 may exert its oncogenic effects, at least partly, by promoting genomic instability.
• SEI-1 is implicated in the progression of ovarian cancer and associated with adverse clinicopathological features.